RhumbLine Advisers’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.06M | Sell |
|
|||||
|
2025
Q2 | $1.43M | Buy |
|
|||||
|
2025
Q1 | $1.31M | Buy |
|
|||||
|
2024
Q4 | $1.94M | Buy |
|
|||||
|
2024
Q3 | $2.04M | Buy |
|
|||||
|
2024
Q2 | $1.85M | Buy |
|
|||||
|
2024
Q1 | $1.14M | Buy |
|
|||||
|
2023
Q4 | $775K | Buy |
|
|||||
|
2023
Q3 | $590K | Buy |
|
|||||
|
2023
Q2 | $730K | Buy |
|
|||||
|
2023
Q1 | $647K | Buy |
|
|||||
|
2022
Q4 | $777K | Buy |
|
|||||
|
2022
Q3 | $913K | Buy |
|
|||||
|
2022
Q2 | $799K | Buy |
|
|||||
|
2022
Q1 | $469K | Buy |
|
|||||
|
2021
Q4 | $925K | Buy |
|
|||||
|
2021
Q3 | $931K | Buy |
|
|||||
|
2021
Q2 | $791K | Buy |
|
|||||
|
2021
Q1 | $753K | Buy |
|
|||||
|
2020
Q4 | $382K | Buy |
|
|||||
|
2020
Q3 | $332K | Buy |
|